100 dating service directory www dating sim com
The OMJ was established in 1984 and has been published under the Oman Medical Specialty Board since 2007.
Initially, we started with one issue a year, which later increased to four and then to six in 2011.
It is distributed free to all medical doctors and allied health professionals in various institutions locally and internationally.
Each author must contribute a significant segment and should take responsibility for the content and authenticity of the work as a whole.
Published manuscripts become the permanent property of Oman Medical Specialty Board.Inhaled insulin was licensed for use in 2006 but has been withdrawn from the market because of low patronage.Oman Medical Journal is an Open Access International Journal, which intends to engage and inform doctors, researchers and other health professionals by publishing a wide range of peer-reviewed articles.Other effective medications include non-sulfonylurea secretagogues, thiazolidinediones, alpha glucosidase inhibitors, and insulin.Recent research into the pathophysiology of type 2 DM has led to the introduction of new medications like glucagon-like peptide 1 analogoues: dipeptidyl peptidase-IV inhibitors, inhibitors of the sodium-glucose cotransporter 2 and 11ß-hydroxysteroid dehydrogenase 1, insulin-releasing glucokinase activators and pancreatic-G-protein-coupled fatty-acid-receptor agonists, glucagon-receptor antagonists, metabolic inhibitors of hepatic glucose output and quick-release bromocriptine.
We now offer our authors and readers the opportunity to access articles before they are published in print with our Ahead-of-Print facility.